Endothelial progenitor cells and the pathogenesis of cerebral malaria

内皮祖细胞与脑型疟疾的发病机制

基本信息

  • 批准号:
    8683073
  • 负责人:
  • 金额:
    $ 40.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-15 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Malaria is a major cause of mortality worldwide. The majority of deaths are due to infections with Plasmodium falciparum (P. falciparum). Cerebral malaria (CM) is a major cause of death in these patients. Despite its virulence, the pathophysiologic basis of CM is poorly understood. Recent investigations suggest that microvascular damage is a factor with associated dysfunction/ dysruption of the blood brain barrier. Endothelial cell damage is caused by several factors including: the sequestration of infected red blood cells, hypoxic damage and "cytokine storm". Repair of damaged microvasculature may occur either by the proliferation of local endothelial cells or the recruitment of bone-marrow derived circulating endothelial progenitor cells (cEPCs). Low levels and dysfunction of cEPCs have been associated with the development of symptoms and adverse events in diseases associated with microvascular damage including cardiovascular disease, diabetes and stroke. Circulating EPC ontogeny and migration from the bone marrow is mediated by chemokines/proteases such as the stromal derived growth factor 1 (SDF-1) and the matrix metalloprotein-9 (MMP-9). We hypothesize that P. falciparum infection results in an imbalance between microvascular damage and repair. Cerebral malaria occurs when cEPCs are diminished and damaged endothelial cells cannot be replaced. A R21 supported study supports this hypothesis. The mean percentage of cEPCs are significantly lower in Ghanaian children with CM as compared to those with uncomplicated malaria (UM), asymptomatic parasitemia (AP) or healthy controls (HC) (p<0.0001). In addition, mean plasma levels of SDF-1 are significantly increased in children with CM and UM as compared to those with AP or HC (p<0.001). The Specific Aims of this proposal will further define the host response to microvascular damage in malaria and determine its association with the development of or recovery from CM. P. falciparum-infected children in Ghana with different degrees of disease severity (CM, UM and AP) will be compared with healthy controls. Aim 1) To determine the time course of the host response to microvascular damage. Levels of cEPCs, SDF-1 and MMP-9 will be measured prospectively in the same patient. We predict that patients with UM who develop CM should have decreasing cEPC levels leading to the development of CM. Increases in cEPCs should be detected in patients who recover from CM. SDF-1 and MMP-9 levels should be elevated in patients who develop CM and decline with recovery. Aim 2) To assess the function of circulating EPCs in malaria infections. Transwell migration assays and blood outgrowth endothelial cell culture coupled with DiLDL metabolic labeling will be performed. We predict that the cEPCs of patients with CM will have functional abnormalities. Aim 3) To assess qRT-PCR assays for the determination of cEPC levels. Quantitative RT-PCR is potentially a facile tool for use in endemic areas for determining cEPC levels as well as assessing function. The utility of qRT-PCR will be assessed in comparison to flow cytometry analysis and functional assays.
描述(由申请人提供):疟疾是全世界死亡的主要原因。大多数死亡是由于感染恶性疟原虫(P. falciparum)造成的。脑型疟疾(CM)是这些患者死亡的主要原因。尽管其毒力,CM的病理生理基础是知之甚少。最近的研究表明,微血管损伤是与血脑屏障功能障碍/破坏相关的一个因素。内皮细胞损伤是由几个因素引起的,包括:受感染的红细胞的隔离,缺氧损伤和“细胞因子风暴”。受损微血管的修复可以通过局部内皮细胞的增殖或骨髓来源的循环内皮祖细胞(cEPCs)的募集来发生。cEPCs的低水平和功能障碍与微血管损伤相关疾病(包括心血管疾病、糖尿病和中风)的症状和不良事件的发生相关。循环EPC个体发生和从骨髓的迁移由趋化因子/蛋白酶如基质衍生生长因子1(SDF-1)和基质金属蛋白-9(MMP-9)介导。我们假设恶性疟原虫感染导致微血管损伤和修复之间的不平衡。当cEPCs减少并且受损的内皮细胞不能被替换时,发生脑型疟疾。R21支持的研究支持这一假设。加纳CM儿童中cEPC的平均百分比显著低于无并发症疟疾(UM)、无症状寄生虫血症(AP)或健康对照(HC)儿童(p<0.0001)。此外,与AP或HC儿童相比,CM和UM儿童的平均血浆SDF-1水平显著升高(p<0.001)。该提案的具体目标将进一步定义宿主对疟疾微血管损伤的反应,并确定其与CM发展或恢复的关系。将加纳感染恶性疟原虫的不同疾病严重程度(CM、UM和AP)的儿童与健康对照进行比较。目的1)确定宿主对微血管损伤反应的时间进程。将在同一患者中前瞻性测量cEPC、SDF-1和MMP-9的水平。我们预测发生CM的UM患者应具有导致CM发生的cEPC水平降低。在CM恢复的患者中应检测到cEPCs的增加。SDF-1和MMP-9水平应在发生CM的患者中升高,并随恢复而下降。目的2)探讨循环内皮祖细胞在疟疾感染中的作用。将进行Transwell迁移试验和血液生长内皮细胞培养以及DiLDL代谢标记。我们预测CM患者的cEPCs将具有功能异常。目的3)评估用于测定cEPC水平的qRT-PCR方法。定量RT-PCR可能是一种用于流行地区确定cEPC水平以及评估功能的简便工具。将通过与流式细胞术分析和功能测定进行比较来评估qRT-PCR的效用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LINNIE GOLIGHTLY其他文献

LINNIE GOLIGHTLY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LINNIE GOLIGHTLY', 18)}}的其他基金

In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
芯片上血脑屏障功能障碍的体外模型阐明脑型疟疾的发病机制
  • 批准号:
    10911396
  • 财政年份:
    2021
  • 资助金额:
    $ 40.61万
  • 项目类别:
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
芯片上血脑屏障功能障碍的体外模型阐明脑型疟疾的发病机制
  • 批准号:
    10318450
  • 财政年份:
    2021
  • 资助金额:
    $ 40.61万
  • 项目类别:
Global Health Research and Training in malaria and cholera: opportunities for nov
疟疾和霍乱全球卫生研究和培训:十一月的机遇
  • 批准号:
    8679737
  • 财政年份:
    2014
  • 资助金额:
    $ 40.61万
  • 项目类别:
Endothelial progenitor cells and the pathogenesis of cerebral malaria
内皮祖细胞与脑型疟疾的发病机制
  • 批准号:
    8505362
  • 财政年份:
    2011
  • 资助金额:
    $ 40.61万
  • 项目类别:
Endothelial progenitor cells and the pathogenesis of cerebral malaria
内皮祖细胞与脑型疟疾的发病机制
  • 批准号:
    8188626
  • 财政年份:
    2011
  • 资助金额:
    $ 40.61万
  • 项目类别:
Endothelial progenitor cells and the pathogenesis of cerebral malaria
内皮祖细胞与脑型疟疾的发病机制
  • 批准号:
    8301571
  • 财政年份:
    2011
  • 资助金额:
    $ 40.61万
  • 项目类别:
Endothelial progenitor cells and malaria pathogenesis
内皮祖细胞和疟疾发病机制
  • 批准号:
    7140305
  • 财政年份:
    2005
  • 资助金额:
    $ 40.61万
  • 项目类别:
Endothelial progenitor cells and malaria pathogenesis
内皮祖细胞和疟疾发病机制
  • 批准号:
    6961033
  • 财政年份:
    2005
  • 资助金额:
    $ 40.61万
  • 项目类别:
MECHANISMS OF MALARIA SEXUAL STAGE GENE EXPRESSION
疟疾性阶段基因表达机制
  • 批准号:
    6195660
  • 财政年份:
    2000
  • 资助金额:
    $ 40.61万
  • 项目类别:
MECHANISMS OF MALARIA SEXUAL STAGE GENE EXPRESSION
疟疾性阶段基因表达机制
  • 批准号:
    6374365
  • 财政年份:
    2000
  • 资助金额:
    $ 40.61万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 40.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 40.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
  • 批准号:
    23K14452
  • 财政年份:
    2023
  • 资助金额:
    $ 40.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
  • 批准号:
    23KJ0074
  • 财政年份:
    2023
  • 资助金额:
    $ 40.61万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
  • 批准号:
    10735765
  • 财政年份:
    2023
  • 资助金额:
    $ 40.61万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 40.61万
  • 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
  • 批准号:
    10583807
  • 财政年份:
    2023
  • 资助金额:
    $ 40.61万
  • 项目类别:
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
  • 批准号:
    10601679
  • 财政年份:
    2023
  • 资助金额:
    $ 40.61万
  • 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
  • 批准号:
    10575222
  • 财政年份:
    2023
  • 资助金额:
    $ 40.61万
  • 项目类别:
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
  • 批准号:
    10752968
  • 财政年份:
    2023
  • 资助金额:
    $ 40.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了